Entrada Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRDA and other ETFs, options, and stocks.About TRDA
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index.
CEODipal Doshi
CEODipal Doshi
Employees183
Employees183
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2016
Founded2016
Employees183
Employees183
TRDA Key Statistics
Market cap426.29M
Market cap426.29M
Price-Earnings ratio-4.23
Price-Earnings ratio-4.23
Dividend yield—
Dividend yield—
Average volume214.74K
Average volume214.74K
High today$10.63
High today$10.63
Low today$9.99
Low today$9.99
Open price$10.39
Open price$10.39
Volume297.08K
Volume297.08K
52 Week high$14.27
52 Week high$14.27
52 Week low$4.93
52 Week low$4.93
Stock Snapshot
As of today, Entrada Therapeutics(TRDA) shares are valued at $10.58. The company's market cap stands at 426.29M, with a P/E ratio of -4.23.
During the trading session on 2026-01-14, Entrada Therapeutics(TRDA) shares reached a daily high of $10.63 and a low of $9.99. At a current price of $10.58, the stock is +5.9% higher than the low and still -0.5% under the high.
Trading volume for Entrada Therapeutics(TRDA) stock has reached 297.08K, versus its average volume of 214.74K.
The stock's 52-week range extends from a low of $4.93 to a high of $14.27.
The stock's 52-week range extends from a low of $4.93 to a high of $14.27.
People also own
Based on the portfolios of people who own TRDA. This list is generated using Robinhood data, and it’s not a recommendation.